Celularity Inc (CELU)
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Celularity Inc.
NASDAQ:CELUHealthcare · Biotechnology
-6.89%$0.9777
AH Close$0.9777+0.00%vs close
AH Close$0.9777+0.00%vs close
Mkt Cap$31.73M
Float7.11M
O/S32.45M
Inst Own6.7%
SI5.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$26.55M
Net Income-$91.72M
Total Assets$107.33M
Free Cash Flow-$13.25M
Debt & Equity
Debt 1441%
Total Debt$40.9M
Total Equity-$38.06M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:10Reverse splitFeb 29, 202410 shares → 1
Balance Sheet Details
Assets$107.33M
Liabilities$145.39M
Accounts Receivable$4.65M
Accounts Payable$26.42M
Inventory$571K
PP&E (Net)$66.52M
Goodwill$7.35M
Intangible Assets$7.76M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $26.55M | $54.22M | $22.77M | $17.98M | $21.34M | $14.28M | $21.15M | $17.55M |
| YoY Growth | -51.0% | 138.1% | 26.7% | -15.7% | 49.4% | -32.5% | 20.5% | - |
| Cost of Revenue | $20.07M | $14.99M | $16.02M | $19.66M | $9.65M | $4.93M | $6.32M | $6.55M |
| Gross Profit | $6.48M | $39.23M | $6.75M | -$1.69M | $11.68M | $9.35M | $14.82M | $11M |
| Gross Margin | 24.4% | 72.4% | 29.7% | -9.4% | 54.8% | 65.5% | 70.1% | 62.7% |
| Research and Development | $15.03M | $17.39M | $30.46M | $78.36M | $88.35M | $52.71M | $46.05M | $29.06M |
| Selling, General, and Administrative | $51.27M | $58.64M | $50.58M | $66.02M | $71.34M | $31.34M | $41.79M | $1K |
| Other | $1.49M | $1.56M | $118M | -$120.47M | -$38.95M | $77.23M | $191.11M | -$31.6M |
| Total Operating Expenses | $67.78M | $77.59M | $199.04M | $23.91M | $120.74M | $161.27M | $278.95M | $1K |
| Operating Income (EBIT) | -$61.31M | -$38.36M | -$192.29M | -$25.6M | -$109.06M | -$151.93M | -$264.13M | -$1K |
| Operating Margin | -230.9% | -70.7% | -844.4% | -142.4% | -511.2% | -1064.0% | -1249.0% | -0.0% |
| Interest Expense | $6.75M | $6.26M | $3.02M | $0 | $3.17M | $2.35M | $0 | $0 |
| Interest Income | $262K | $331K | $320K | $365K | $332K | $370K | $694K | $628K |
| Other Income (Expense) | -$30.41M | -$19.53M | -$4M | $39.8M | $8.96M | -$61.01M | -$3.87M | $2 |
| Income Before Tax (EBT) | -$91.71M | -$57.89M | -$196.28M | $14.21M | -$100.1M | -$212.93M | -$267.99M | -$1K |
| Income Tax Expense | $3K | $0 | $10K | $13K | $20K | -$4.7M | -$56.11M | $0 |
| Net Income | -$91.72M | -$57.89M | -$196.29M | $14.19M | -$100.12M | -$208.23M | -$211.88M | -$1K |
| Net Income Margin | -345.4% | -106.8% | -862.0% | 79.0% | -469.3% | -1458.4% | -1001.9% | -0.0% |
| Supplementary Data | ||||||||
| EPS | -3.59 | -2.64 | -11.02 | 1.01 | -7.87 | -113.06 | -88.75 | 0.00 |
| Diluted EPS | -3.59 | -2.64 | -11.02 | 0.95 | -7.87 | -113.06 | -88.75 | 0.00 |
| Weighted Average OS | 25.60M | 21.89M | 17.81M | 13.99M | 12.73M | 1.84M | 2.39M | 3.59M |
| EBITDA | -$77.66M | -$43.71M | -$183.95M | -$138.83M | -$88.11M | -$202.41M | -$70.98M | -$1K |
| EBITDA Margin | -292.5% | -80.6% | -807.8% | -772.4% | -413.0% | -1417.6% | -335.6% | -0.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $6.17M | $738K | $227K | $13.97M | $37.24M | $54.31M | $28.13M | $25K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $6.17M | $738K | $227K | $13.97M | $37.24M | $54.31M | $28.13M | $25K |
| Accounts Receivable | $4.65M | $13.56M | $12.12M | $6.97M | $5.23M | $6.55M | $3.08M | $3.92M |
| Inventory | $571K | $5.41M | $5.75M | $5.31M | $9.55M | $3.85M | $3.23M | $3.54M |
| Other Current Assets | $222K | $857K | $329K | $1.05M | $2K | $873K | $480K | $1.49M |
| Total Current Assets | $12.32M | $20.56M | $19.79M | $33.5M | $59.1M | $72.16M | $36.81M | $25K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $66.52M | $72.43M | $78.82M | $88.72M | $90.63M | $90.08M | $66.39M | $4.01M |
| Goodwill | $7.35M | $7.35M | $7.35M | $119.69M | $123.3M | $123.3M | $127.07M | $130.64M |
| Intangible Assets | $7.76M | $9.25M | $11M | $120.99M | $123.19M | $125.38M | $271.47M | $393.71M |
| Long-Term Investments | $0 | $10.24M | $9.94M | $14.84M | $14.84M | $15.2M | $291M | $0 |
| Deferred Tax Assets | $0 | $0 | -$9.94M | $9K | $0 | $0 | $2K | $0 |
| Other Long-Term Assets | $13.39M | $12.86M | $26.93M | $23.32M | $3.08M | $4.89M | -$271.24M | $4K |
| Total Long-Term Assets | $95.01M | $112.12M | $124.1M | $367.56M | $355.03M | $358.85M | $484.69M | $532K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$532.17M |
| Total Assets | $107.33M | $132.68M | $143.89M | $401.07M | $414.13M | $431.01M | $521.5M | $25K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $26.42M | $23.3M | $14.14M | $5.81M | $9.32M | $5.39M | $19K | $5.27M |
| Short-Term Debt | $14M | $6.36M | $39.24M | $37.6M | $3.05M | $3.01M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $19K | $0 |
| Current Unearned Revenue | $5.25M | $3.53M | $2.83M | $2.27M | $2.2M | $5.12M | $0 | $0 |
| Other Current Liabilities | $6.92M | $1.6M | $8.07M | $13.83M | $7.83M | $8.17M | $11.23M | -$11K |
| Total Current Liabilities | $80.76M | $53.68M | $67.3M | $62.09M | $26.23M | $26.68M | $20.64M | $151K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $35.93M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $2.8M | $2.72M | $3.19M | $2.22M | $1.87M | $7.62M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $12K | $9K | $9K | $9K | $10K | $7K | $0 | $0 |
| Other Long-Term Liabilities | $34.92M | $4.96M | $6.26M | $109.86M | $258.52M | $350.36M | $334.94M | $0 |
| Total Long-Term Liabilities | $64.63M | $70.17M | $35.63M | $140.08M | $288.48M | $385.62M | $363M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $145.39M | $123.84M | $102.93M | $202.16M | $314.71M | $412.3M | $383.63M | $151K |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $550.11M | $465.28M | $340.28M |
| Common Stock | $3K | $2K | $19K | $15K | $12K | $1K | $1K | $863 |
| Retained Earnings | -$991.48M | -$899.68M | -$841.79M | -$645.5M | -$663.68M | -$563.56M | -$355.33M | -$1K |
| Comprehensive Income & Other | $0 | -$5K | $0 | $9K | $0 | $0 | $0 | -$150K |
| Other Stockholders' Equity | $953.42M | $908.52M | $882.73M | $844.38M | $763.09M | $582.27M | $493.19M | -$126K |
| Total Equity | -$38.06M | $8.84M | $40.96M | $198.9M | $99.42M | $18.71M | $137.86M | -$126K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $107.33M | $132.68M | $143.89M | $401.07M | $414.13M | $431.01M | $521.5M | $25K |
| Supplementary Data | ||||||||
| Total Debt | $40.9M | $68.84M | $65.42M | $65.59M | $31.14M | $30.64M | $28.06M | $150K |
| Net Debt | $34.73M | $68.1M | $65.19M | $51.62M | -$6.1M | -$23.67M | -$66K | $125K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$91.72M | -$57.89M | -$196.29M | $14.19M | -$100.12M | -$208.23M | $5.88M | -$13.38M |
| Depreciation & Amortization | $7.29M | $7.92M | $9.32M | $9.44M | $8.82M | $8.17M | $6.19M | $4.79M |
| Deferred Income Tax | $3K | $0 | $0 | $0 | $0 | -$8.48M | -$2K | $0 |
| Stock-Based Compensation | $10.38M | $11.57M | $15.02M | $15.86M | $40.01M | $4.37M | $0 | $4.5M |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $7.55M | -$3.97M | -$6.83M | -$3.58M | -$1.91M | $1.65M | $0 | -$2.29M |
| Inventory | $10.25M | $6.28M | -$865K | -$16.89M | -$6.42M | -$643K | $0 | -$3.4M |
| Accounts Payable | $3.13M | $9.24M | $0 | $0 | $0 | $314K | $19K | $0 |
| Other Working Capital | $12.67M | $10.64M | $919K | $5.02M | $2.62M | $2.28M | $118K | $4.35M |
| Total Working Capital Change | $33.59M | $22.2M | -$6.77M | -$15.45M | -$5.71M | $3.6M | $136K | -$1.34M |
| Other Non-Cash Items | $27.19M | $9.8M | $140.04M | -$161.91M | -$53.1M | $137.37M | -$13.3M | -$54.54M |
| Net Cash from Operating | -$13.25M | -$6.4M | -$38.69M | -$137.88M | -$110.1M | -$63.19M | -$1.1M | -$543 |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | -$161K | -$4.05M | -$5.24M | -$6.2M | -$27.83M | $0 | -$1.92M |
| Acquisitions | $0 | -$1.5M | $0 | $0 | $0 | $15.02M | $0 | -$29.28M |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | -$287.5M | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $2.17M | $0 | $0 | $300K | $0 | $651K | $14K |
| Net Cash from Investing | $0 | $514K | -$4.05M | -$5.24M | -$5.9M | -$12.81M | -$286.85M | -$31.18M |
| Financing Activities | ||||||||
| Debt Repaid | - | -$6M | -$25.13M | - | - | - | - | - |
| Common Stock Issuance | $24.41M | $58K | $5.43M | $53.37M | $638K | $0 | $288.99M | $25K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$256K | $0 | $0 |
| Dividends Paid | -$5.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $255K | -$459K | $7.35M | $27.26M | $97.92M | -$265K | $0 | $250 |
| Net Cash from Financing | $18.65M | $6.7M | $24.09M | $119.84M | $98.56M | $102.01M | $288.84M | $25K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $5.39M | $814K | -$18.64M | -$23.27M | -$17.44M | $26.01M | $892K | -$31.16M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$13.25M | -$6.4M | -$38.69M | -$137.88M | -$110.1M | -$63.19M | -$1.1M | -$543 |
| Capital Expenditure | $0 | -$161K | -$4.05M | -$5.24M | -$6.2M | -$27.83M | $3 | -$1.92M |
| Free Cash Flow | -$13.25M | -$6.56M | -$42.73M | -$143.11M | -$116.3M | -$91.03M | -$1.1M | -$1.92M |
| Cash at Beginning | $10.98M | $10.16M | $28.8M | $52.08M | $69.51M | $43.51M | $25K | $31.18M |
| Cash at End | $16.37M | $10.98M | $10.16M | $28.8M | $52.08M | $69.51M | $917K | $25K |